3rd BELNUC Radioligand Therapy Course

Published on: August 21, 2026

3rd BELNUC Radioligand Therapy Course

  • Date: November 28, 2026
  • Venue: Sheraton Brussels Airport, 1930 Brussels, Belgium

Registration is now open!

The Deadline for registration is on November 20, 2026 (23:59 CET)

Participant / Ticket Type Early Registration
(until 18/10/2026)
Late Registration
(19/10 until 20/11/2026)
BELNUC Member 110 € 175 €
Non-Member 175€ 225€
BELNUC Technologist Member 75€ 125€
Technologist Non-Member 100 € 150 €
Student / Resident 50 € 75 €
Optional parking voucher Brussels Airport Interparking
(P1 Front Park, P2 Economy, or P3 Holiday parking)
10€ 10€

The industry exhibition setup will be published in due time.


Same format, Same place, More great content!

We are extremely pleased to announce the 3rd BELNUC Radioligand Therapy Course, taking place on Saturday, 28 November 2026 at the Sheraton Brussels Airport Hotel.

The annual BELNUC Radioligand Therapy Course is rapidly establishing itself as a leading educational event in the clinical practice of targeted radionuclide therapy in Belgium.

Following the highly successful first edition in 2024  and last years  second edition in 2025, which brought together over 200 participants, 13 industry exhibitors and 17 expert speakers, and received overwhelmingly positive feedback, this third edition will again welcome a multidisciplinary audience of clinicians, physicists, radiopharmacists, nurses, technologists, industry representatives and experts involved in radioligand therapy (RLT) combined with interactive case based and panel discussions.

The BELNUC RLT Course offers a rich platform for sharing practical insights, clinical challenges, and forward-looking innovations in RLT delivery. Participants will benefit from engaging lectures, expert-led case discussions, and valuable opportunities to connect with peers and industry partners.

New this year is the opportunity for participants to present their own challenging clinical cases.

 


Preliminary Programme

MORNING PROGRAMME
MAIN AUDITORIUM EXHIBITION/HANDS-ON AREA
08:30-09:00

Registration & Welcome


09:00-10:30 Back to basics
Moderator: prof. dr. Tim Van den Wyngaert


09:00-09:30:

Designing biological effect in RLT: state-of-the-art in therapeutic radiopharmaceuticals.
prof. dr. Margret Schottelius (Centre Hospitalier Universitaire Vaudois {CHUV}, Lausanne Switzerland)


09:30-10:00:

Radiobiology for clinicians: why RLT works – or fails – across radionuclides.
prof .dr. Julie Nonnekens (Erasmus MC, Rotterdam, The Netherlands)


10:00-10:30:

Conversation with the Experts: From Evidence to Practice

Exhibitor setup
10:30-11:00

Coffee Break


Dosimetry/Equipment demonstrations
11:00-12:15 Challenging cases in PRRT
Moderator: dr. Niloefar Ahmadi Bidhakvid


Interactive case discussion + bring your own case

Dosimetry/Equipment demonstrations
12:15-13:15

Lunch


Exhibition
AFTERNOON PROGRAMME
MAIN AUDITORIUM EXHIBITION/HANDS-ON AREA
13:15-14:30

Challenging cases in mCRPC RLT
Moderatordr. Olivier de Winter


Interactive case discussion + bring your own case

14:30-15:00

Coffee Break


Dosimetry/Equipment demonstrations
Excellence without exclusion: Organizing quality RLT care
Moderator: prof. dr. Tim van den Wyngaert


15:00-15:30

EARL Centres of Excellence (CoE) in RLT: quality framework or access
barrier in the Belgian landscape?

prof. dr. Michel Koole (UZ Leuven)


15:30-16:00

Conversation with the Experts: Controversies and Consensus


Dosimetry/Equipment demonstrations
Please note that this program is preliminary and may be changed without notice.

📣 Call for Challenging Cases 📣 

Got a case that kept you up at night? We want it!

The 3rd BELNUC Radioligand Therapy Course (Saturday 28 November 2026, Sheraton Brussels Airport) is opening its floor to you. We’re inviting challenging clinical cases in PRRT and mCRPC RLT for a short 5-minute presentation, followed by a lively, interactive discussion with our expert panel and the room.

Priority for young professionals (≤38 years)! If you’ve wrestled with a tricky case and have a question worth debating, we will give you priority on the stage. A friendly, high-level audience, real-time expert input, and a great line for your CV. No polished success stories required; the harder the case, the better the discussion.

What makes a great submission? A genuinely difficult real-world clinical management challenge, built around one clear question for the panel, with the relevant clinical context and supporting data (imaging, dosimetry, labs, follow-up).

Topics open for submission

  • PRRT: non-NET indications, SSTR-positive/FDG-avid disease, transition from β- to α-emitters in NET
  • PSMA-RLT: FDG-positive disease, toxicity management, complete/mixed response, oligoprogression, bone-only disease

How to get on stage

  1. Complete the Case Submission Form
  2. Add a short CV (max 1 page)
  3. Send it to Niloefar Ahmadi Bidakhvidi (PRRT) or Olivier De Winter (mCRPC RLT)

🗓️ Deadline: Sunday 20 September 2026, 23:59 CET.

Selected presenters notified by October 1st.

We welcome your real-world contributions and look forward to a stimulating scientific exchange!


We would like to thank all Sponsors of the 3rd BELNUC RLT Course!


How to use the parking voucher?

  • Use one of the following parking facilities at Brussels Airport: P1 Front Park, P2 Economy, or P3 Holiday parking. The voucher can only be used at these parkings.
  • Take your parking ticket at the entrance.
  • Collect your voucher at the BELNUC registration desk.
  • Upon your return, go to one of the payment machines of your parking before retrieving your vehicle.
  • Insert your parking ticket into the payment machine first, followed by your voucher. Pay any remaining balance if applicable. Take your ticket back, as you will need it to exit the parking.

FANC/AFCN has accredited:

  • 5u00 voor Nuclearisten
  • 5u00 voor Stralingsfysicus NG
  • 2u00 voor Gemachtigden NG

RIZIV/INAMI accreditation has been requested, including Ethics & Economy.